Coagulopathy is a major extrapulmonary risk factor for mortality in hospitalized patients with COVID-19 with type 2 diabetes

Authors:

Abstract
Introduction To investigate the risk factors for the death in patients with COVID-19 with type 2 diabetes mellitus (T2DM). Research design and methods We retrospectively enrolled inpatients with COVID-19 from Wuhan Jinyintan Hospital (Wuhan, China) between December 25, 2019, and March 3, 2020. The epidemiological and clinical data were compared between non-T2DM and T2DM or between survivors and non-survivors. Univariable and multivariable Cox regression analyses were used to explore the effect of T2DM and complications on in-hospital death. Results A total of 1105 inpatients with COVID-19, 967 subjects with without T2DM (n=522 male, 54.0%) and 138 subjects with pre-existing T2DM (n=82 male, 59.4%) were included for baseline characteristics analyses. The complications were also markedly increased in patients with pre-existing T2DM, including acute respiratory distress syndrome (ARDS) (48.6% vs 32.3%, pConclusions Coagulopathy was a major extrapulmonary risk factor for death in inpatients with COVID-19 with T2DM rather than ACI and AKI, which were well associated with mortality in inpatients with COVID-19 without T2DM.
Funding Information
  • Shanghai Top-Priority Clinical Key Disciplines Construction Project (2017ZZ02013)
  • Prevention and Treatment of Infection in Novel Coronavirus Pneumonia Patients from the Science and Technology Committee of Shanghai Municipality (20411950402)
  • Shanghai Municipal Key Clinical Specialty (shslczdzk02201)
  • the Sub-specialist project of Qingpu Branch of Zhongshan Hospital, Fudan University (YZK 2019-04)
  • the National Natural Science Foundation of China (NSFC) for Novel Coronavirus Pneumonia (82041003)
  • the Shanghai key discipline of medicine (ZK2019B07 SZ2019-1)

This publication has 27 references indexed in Scilit: